[go: up one dir, main page]

CY1109233T1 - Προφυλακτικη και θεραπευτικη χρηση υδροξυστεροειδων - Google Patents

Προφυλακτικη και θεραπευτικη χρηση υδροξυστεροειδων

Info

Publication number
CY1109233T1
CY1109233T1 CY20091100767T CY091100767T CY1109233T1 CY 1109233 T1 CY1109233 T1 CY 1109233T1 CY 20091100767 T CY20091100767 T CY 20091100767T CY 091100767 T CY091100767 T CY 091100767T CY 1109233 T1 CY1109233 T1 CY 1109233T1
Authority
CY
Cyprus
Prior art keywords
hydroxysteroids
preventive
therapeutic use
hydroxy
steroids
Prior art date
Application number
CY20091100767T
Other languages
English (en)
Inventor
Ernst Wülfert
Original Assignee
Hunter-Fleming Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter-Fleming Limited filed Critical Hunter-Fleming Limited
Publication of CY1109233T1 publication Critical patent/CY1109233T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Τα 3-υδροξυ-7-υδροξυ στεροειδή και τα 3-οξο-7-υδροξυ στεροειδή, ιδιαίτερα τα 7β-ισομερή αυτών, και οι φαρμακευτικά αποδεκτοί εστέρες αυτών είναι χρήσιμα για προστασία έναντι προκαλούμενης από ισχαιμία βλάβης σε περιφερικά όργανα, όπως η καρδιά ή οι νεφροί, καθώς και για θεραπεία τραυματισμού νωτιαίου μυελού.
CY20091100767T 2001-08-14 2009-07-20 Προφυλακτικη και θεραπευτικη χρηση υδροξυστεροειδων CY1109233T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0119810A GB2378898A (en) 2001-08-14 2001-08-14 Prophylactic and therapeutic use of hydroxysteroids
EP02755176A EP1416937B1 (en) 2001-08-14 2002-08-13 Prophylactic and therapeutic use of hydroxysteroids

Publications (1)

Publication Number Publication Date
CY1109233T1 true CY1109233T1 (el) 2014-07-02

Family

ID=9920376

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100767T CY1109233T1 (el) 2001-08-14 2009-07-20 Προφυλακτικη και θεραπευτικη χρηση υδροξυστεροειδων

Country Status (19)

Country Link
US (1) US8148355B2 (el)
EP (1) EP1416937B1 (el)
JP (1) JP4541698B2 (el)
KR (1) KR100895281B1 (el)
CN (1) CN1700920B (el)
AT (1) ATE429919T1 (el)
AU (1) AU2002321472B2 (el)
CA (1) CA2457050C (el)
CY (1) CY1109233T1 (el)
DE (1) DE60232154D1 (el)
DK (1) DK1416937T3 (el)
ES (1) ES2324859T3 (el)
GB (1) GB2378898A (el)
IL (2) IL160362A0 (el)
NO (1) NO334819B1 (el)
NZ (1) NZ531100A (el)
PT (1) PT1416937E (el)
RU (1) RU2329049C2 (el)
WO (1) WO2003015791A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US7910755B2 (en) 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
HRP20120687T1 (hr) * 2006-11-30 2012-09-30 Hunter-Fleming Limited Moduliranje metabolizma prostaglandina/ciklooksigenaze
GB0623971D0 (en) * 2006-11-30 2007-01-10 Hunter Fleming Ltd Modulation of prostaglandin/cyclooxygenase metabolic pathways
EP2653163A1 (en) * 2012-04-19 2013-10-23 Université de Liège Estrogenic components for use in the treatment of neurological disorders
CN105078954A (zh) * 2015-08-20 2015-11-25 南京华宽信息咨询中心 一种治疗急性肾衰药物及其应用
CN105168197A (zh) * 2015-08-22 2015-12-23 南京华宽信息咨询中心 一种治疗肾功能不全药物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686438A (en) * 1993-03-09 1997-11-11 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US5846963A (en) * 1995-06-07 1998-12-08 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US5977095A (en) * 1993-03-09 1999-11-02 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
KR960700728A (ko) * 1993-03-09 1996-02-24 토마스 메이져 진행성 조직 괴사, 재관류 손상, 세균 전이 및 성인 호흡 장애 증후군의 예방 방법(Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome)
US5753640A (en) * 1995-06-07 1998-05-19 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
IT1282289B1 (it) * 1995-06-23 1998-03-16 Sigma Tau Ind Farmaceuti 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare,
WO1999011271A1 (en) 1997-08-29 1999-03-11 Dalhousie University Use of polycyclic steroid compounds for the manufacture of a medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions
AU3467699A (en) * 1998-04-14 1999-11-01 Pharmadigm, Inc. Method for reducing central nervous system impairment
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2363984A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids

Also Published As

Publication number Publication date
IL160362A0 (en) 2004-07-25
PT1416937E (pt) 2009-07-24
EP1416937B1 (en) 2009-04-29
DK1416937T3 (da) 2009-08-24
NZ531100A (en) 2006-02-24
DE60232154D1 (de) 2009-06-10
GB0119810D0 (en) 2001-10-10
US8148355B2 (en) 2012-04-03
CN1700920B (zh) 2012-05-30
IL160362A (en) 2011-10-31
JP2005506321A (ja) 2005-03-03
KR100895281B1 (ko) 2009-04-29
NO20041057L (no) 2004-03-12
KR20040041577A (ko) 2004-05-17
HK1065703A1 (en) 2005-03-04
GB2378898A (en) 2003-02-26
JP4541698B2 (ja) 2010-09-08
CN1700920A (zh) 2005-11-23
EP1416937A1 (en) 2004-05-12
RU2004104362A (ru) 2005-05-10
CA2457050C (en) 2010-10-12
RU2329049C2 (ru) 2008-07-20
ES2324859T3 (es) 2009-08-18
NO334819B1 (no) 2014-06-10
AU2002321472B2 (en) 2007-11-08
CA2457050A1 (en) 2003-02-27
WO2003015791A1 (en) 2003-02-27
ATE429919T1 (de) 2009-05-15
US20040248868A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
CY1109233T1 (el) Προφυλακτικη και θεραπευτικη χρηση υδροξυστεροειδων
CY1121113T1 (el) Θεραπεια της νοσου ρομρε
CY1118480T1 (el) Παραγωγα toy uk-2a
CY1105834T1 (el) Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων
CY1105078T1 (el) Ανταγωνιστες τεκ
CY1119481T1 (el) Εισπνευσιμη επινεφρινη
DE69408309D1 (de) Mittel zum künstlichen sonnenbräunen und zum schutz der haut gegen uv-strahlen
NO20060971L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
CY1114708T1 (el) Παραγωγα πυραζολο-κιναζολινης, διαδικασια για την παρασκευη τους και η χρηση τους ως αναστολεων κινασης
EA200500149A1 (ru) Тканевые протективные цитокины для защиты, восстановления и стимуляции реактивных клеток, тканей и органов
DOP2002000456A (es) Inhibidores de la alquin-aril fosfodiesterasa-4''
CY1108211T1 (el) Προφυλακτικη και θεραπευτικη αγωγη των μολυσματικων, αυτοανοσων και αλλεργικων νοσων με ενωσεις βασης μονοσακχαριτη
DK0933995T3 (da) Fremgangsmåde til behandling af endotelskader
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
CY1116511T1 (el) Μεθοδος αγωγης του κολπικου ινιδισμου
CY1117584T1 (el) Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, cx3cr1
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
DE60209721D1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
BRPI0418157A (pt) terapêutica de tumores alogênicos
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
CY1106026T1 (el) Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας
DE60026046D1 (de) 5-hydroxysapogenin derivate mit aktivität gegen demenz
NO20034561D0 (no) Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες